A Rare Cause of Retroperitoneal Fibrosis in Adults: H Syndrome Presenting After 35 Years- A Case Report

Authors

  • Türker Emre Department of Nephrology, University of Health Sciences, Bursa City Training and Research Hospital, Bursa, Turkey. Author
  • Nazife Nur Özer Şensoy 2Department of Nephrology, University of Health Sciences, Bursa City Training and Research Hospital, Bursa, Turkey. Author https://orcid.org/0000-0001-8809-2250

DOI:

https://doi.org/10.61882/npz6gc25

Keywords:

Retroperitoneal fibrosis, H syndrome, SLC29A3gene mutation, Adult onset H syndrome, Renal failure

Abstract

Introduction. Retroperitoneal  fibrosis  (RPF)  is  a  rare  fibro- inflammatory  disorder  that  may  cause  urinary  tract  obstruction and renal failure. Although most RPF cases are IgG4-related, rare genetic conditions can also contribute to the disease. H syndrome, an  autosomal  recessive  disorder  caused  by  biallelic  SLC29A3 mutations, usually presents in childhood with cutaneous, endocrine, and systemic manifestations; adult onset is exceptionally rare. Case presentation. A 36-year-old woman was admitted to hospital with the complaint of nausea, vomiting, and oliguria. Laboratory tests showed urea 116 mg/dL, creatinine 5,8 mg/dL,. Non-contrast computed tomography imaging revealed bilateral hydronephrosis and a 2,5 cm retroperitoneal fibrotic mass encasing the abdominal aorta and iliac arteries. Extensive evaluation—including positron emission tomography, lymph-node histology, and autoimmune/ IgG4 serology—found no evidence of malignancy, infection, or IgG4- related  disease.  Family  history  disclosed  parental  consanguinity and  a  brother  with  H  syndrome.  Next-generation  sequencingidentified  a  homozygous  SLC29A3  (NM_018344.5):c.1339G > A (p.Glu447Lys) mutation, confirming H syndrome. Bilateral ureteral stenting  and  corticosteroid  therapy  led  to  full  renal  recovery
(creatinine 0.7 mg/dL).
Conclusion. This case expands the clinical spectrum of H syndrome by  documenting  late-onset  RPF  without  typical  dermatologic  or auditory  signs.  Recognition  of  familial  risk  and  timely  genetic testing  were  decisive  for  diagnosis.  Early  decompression  and immunosuppression  preserved  renal  function.  Reporting  suchatypical  presentations  increases  awareness  of  H  syndrome  as  a rare  genetic  cause  of  RPF  and  supports  comprehensive  genetic evaluation in adults with unexplained retroperitoneal fibrosis.

Downloads

Download data is not yet available.

References

1. Fenaroli P, Maritati F, Vaglio A. Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis. Curr Rheumatol Rep. 2021 Feb 10;23(3):18.

2. Duhan S, Keisham B, Bazigh K, Duhan C, Alhamdan N. Retroperitoneal Fibrosis: Still a Diagnostic Challenge. Cureus. 2023 Jan 20;15(1):e33998.

3. Honsali R, Tahiri L, Cherkaoui-Dekkaki S, Allali F. Rheumatological manifestations of H syndrome. Reumatologia. 2024;62(4):294-303.

4. Bloom JL, Lin C, Imundo L, Guthery S, Stepenaskie S, Galambos C, Lowichik A, Bohnsack JF. H syndrome: 5 new cases from the United States with novel features and responses to therapy. Pediatr Rheumatol Online J. 2017 Oct 17;15(1):76.

5. Hamad A, Elwaheidi H, Salameh F, Alyahya M, El Fakih R, Aljurf M. H syndrome: A histiocytosis-lymphadenopathy plus syndrome. A comprehensive review of the literature. Hematol Oncol Stem Cell Ther. 2024 Jul-Sep 01;17(3):159-167.

6. Al-Haddab M, Al Muqarrab FJ, Alhumidi A, Alkofide M. Clinical Progression and Manifestations of H Syndrome: A Case Report of Failed Treatment Option. Am J Case Rep. 2024 Jun 8;25:e944198.

7. Jacquot R, Jouret M, Valentin MG, Richard M, Jamilloux Y, Rousset F, Emile JF, Haroche J, Steinmüller L, Zekre F, Phan A, Belot A, Seve P. H syndrome treated with Tocilizumab: two case reports and literature review. Front Immunol. 2023 Aug 11;14:1061182.

8. Jeremiah N, Awad F, Sticht H, et al. Functional and structural insights into the SLC29A3 transporter: Identifying the molecular basis of H syndrome. J Invest Dermatol. 2014;134(2):557-561.

9. Vural S, Ertop P, Durmaz CD, et al. Skin-Dominant Phenotype in a Patient with H Syndrome: Identification of a Novel Mutation in the SLC29A3 Gene. Cytogenet Genome Res. 2017;151(4):186-190.

10. Fikri C, Aboudouraib M, Sab IA, Amal S, Hocar O. H Syndrome: Three New Cases from Morocco. Skinmed. 2024 Aug 2;22(3):225-227.

11. Tesser A, Valencic E, Boz V, Tornese G, Pastore S, Zanatta M, Tommasini A. Rheumatological complaints in H syndrome: from inflammatory profiling to target treatment in a case study. Pediatr Rheumatol Online J. 2024 Jan 23;22(1):21

Downloads

Published

2025-11-15

Issue

Section

CASE REPORT | Kidney Diseases

How to Cite

A Rare Cause of Retroperitoneal Fibrosis in Adults: H Syndrome Presenting After 35 Years- A Case Report. (2025). Iranian Journal of Kidney Diseases, 19(05), 304-309. https://doi.org/10.61882/npz6gc25

Similar Articles

11-20 of 782

You may also start an advanced similarity search for this article.